A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia
R. Willemze, N. van der Lely, H. Zwierzina, S. Suciu, G. Solbu, H. Gerhartz, B. Labar, G. Visani, M. E. Peetermans, A. Jacobs, P. Stryckmans, P. Fenaux, H. L. Haak, M. M. Ribeiro, E. Baumelou, M. BaccVolume:
64
Langue:
english
Pages:
1
DOI:
10.1007/bf01695479
Date:
June, 1992
Fichier:
PDF, 36 KB
english, 1992
File converter
Plus de résultats de recherche
More benefits 
